Arcturus Therapeutics Holdings Inc Asset Turnover Ratio (ARCT), as of first quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket
 


Arcturus Therapeutics Holdings Inc   (NASDAQ: ARCT)
 

Arcturus Therapeutics Holdings Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Arcturus Therapeutics Holdings Inc 's asset turnover ratio, the ratio that measures the ability of Arcturus Therapeutics Holdings Inc 's assets to generate revenue, sequentially decreased to 0.2 in the first quarter (Mar 31 2026), which does not come as a surprise, as the Arcturus Therapeutics Holdings Inc continue to experience difficult business climate.

Within sector 94 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the I Quarter 2026, to 1779, from total ranking in the fourth quarter 2025 at 1981.

Asset Turnover Ratio Definition



ARCT Asset Turnover Ratio (Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
(Mar 31 2025)
I. Quarter
Y / Y Asset Change -26.03 % -14.06 % -17.24 % -13.66 % -14.39 %
Y / Y Revenue Change -92.99 % -68.39 % -58.84 % -43.24 % -22.7 %
Asset Turnover Ratio (TTM) 0.2 0.27 0.32 0.38 0.43
ARCT's Total Ranking # 1779 # 1981 # 2404 # 1963 # 2207
Seq. Asset Change -9.49 % -3.97 % -8.71 % -6.79 % 5.16 %
Seq. Revenue Change -71.36 % -58.04 % -39.4 % -3.68 % 29.06 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 95
Healthcare Sector # 269
Overall Market # 1779

Asset Turnover Ratio Statistics
High Average Low
0.72 0.32 0.02
(Mar 31 2023)   (Sep 30 2021)







Companies with similar Asset Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Mar 31 2026 Assets at quarter ending Mar 31 2026
Neuraxis Inc   0.61 $ 4.282  Millions$ 7.004  Millions
Heron Therapeutics Inc   0.61 $ 150.184  Millions$ 245.783  Millions
Castle Biosciences Inc   0.61 $ 339.920  Millions$ 558.469  Millions
Onemednet Corporation  0.61 $ 1.139  Millions$ 1.875  Millions
Capsovision Inc   0.60 $ 11.972  Millions$ 19.829  Millions
Vsee Health Inc   0.60 $ 11.786  Millions$ 19.587  Millions
Bionexus Gene Lab Corp   0.60 $ 5.311  Millions$ 8.834  Millions
Globus Medical Inc   0.60 $ 3,100.664  Millions$ 5,199.761  Millions
Cumberland Pharmaceuticals Inc   0.60 $ 41.940  Millions$ 70.406  Millions
Agenus Inc  0.60 $ 123.866  Millions$ 208.092  Millions
Skinhealth Systems Inc   0.60 $ 295.223  Millions$ 496.059  Millions
Mannkind Corporation  0.59 $ 360.783  Millions$ 610.731  Millions
Conmed Corporation  0.59 $ 1,370.514  Millions$ 2,322.909  Millions
Cormedix Inc   0.59 $ 389.749  Millions$ 661.310  Millions
Adaptive Biotechnologies Corporation  0.59 $ 295.407  Millions$ 501.482  Millions
Transmedics Group Inc   0.59 $ 635.890  Millions$ 1,084.937  Millions
Merit Medical Systems Inc  0.58 $ 1,542.047  Millions$ 2,655.562  Millions
Dr Reddy s Laboratories Limited  0.58 $ 3,580.000  Millions$ 6,175.000  Millions
Radnet Inc   0.58 $ 2,144.442  Millions$ 3,706.049  Millions
Solventum Corporation  0.58 $ 8,262.000  Millions$ 14,359.500  Millions
Agilent Technologies inc   0.57 $ 7,232.000  Millions$ 12,686.250  Millions
Steris Plc  0.57 $ 5,935.900  Millions$ 10,424.928  Millions
Logicmark Inc  0.57 $ 12.048  Millions$ 21.159  Millions
Iqvia Holdings Inc   0.57 $ 16,632.000  Millions$ 29,244.500  Millions
Foxo Technologies Inc   0.57 $ 27.325  Millions$ 48.119  Millions
Acadia Healthcare Company Inc   0.57 $ 3,371.066  Millions$ 5,948.750  Millions
Livanova Plc  0.56 $ 1,432.049  Millions$ 2,546.672  Millions
Catalyst Pharmaceuticals Inc   0.56 $ 596.958  Millions$ 1,068.777  Millions
Pacira Biosciences inc   0.55 $ 734.864  Millions$ 1,327.073  Millions
Baxter International Inc   0.55 $ 11,320.000  Millions$ 20,503.500  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.